DART

Production and product commercialization for third parties of pharmaceuticals and substances, namely, bispecific and multi-specific, antibody-based molecules, that bind to two or more targets, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancer, and infectious diseases